Curetis GmbH’s Post

🎬 Discover the power of Patient-Centered Outcomes Research (PCOR) in healthcare. At BioXplore, we’re putting patients first by ensuring their voices shape the future of treatments. Let’s drive better access to therapies that truly matter. Connect with us today to learn how PCOR can transform healthcare in Latin America. #RareDiseaseAwareness #OrphanDrugs #HealthTechnology #PatientAccess #PharmaInnovation #HealthcareStrategy #BioXplore #ValueAssessment #PatientAdvocacy #LifeChangingTherapies #MedicalBreakthroughs #DrugDevelopment #HealthcareSolutions #MarketAccess #PharmaceuticalIndustry

We're all about improving patient care through the highest quality diagnostics. A study published in 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗝𝗼𝘂𝗿𝗻𝗮𝗹 𝗼𝗳 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 highlights the power of Point-of-Care Testing in primary care, showing reduced follow-up visits, fewer phone calls, and faster test results—all leading to more efficient patient care. The numbers speak for themselves: 🔹 𝟮𝟭% decrease in tests ordered per patient 🔹 𝟴𝟵% fewer phone calls to patients 🔹 %𝟲𝟭 decrease in repeat patient visits At General Fluidics, our mission is to empower healthcare providers with the gold standard diagnostic technology that delivers quicker results and enhances operational efficiency. We're excited to see how technologies like POCT are transforming the future of healthcare! 🌍💉 #PointOfCare #Diagnostics #HealthcareInnovation #GeneralFluidics #PatientCare

Have you observed any transaction of diagnostic chains expanding their reach into hospital ownership? Perhaps I am not aware about such cases in recent past. Definitely it is strategic move by Krsnaa for investment in hospitals. I consider following advantages - Vertical integration - patient access - Expanded reach - Diversification - Synergy What is your view ? #growthstrtegy #healthcareindustryinindia #hospitalfinance #https://lnkd.in/dN_tvype

If you're in MedTech and planning your product launch strategy for the NHS, we've got the perfect webinar for you! Register for free below and don't miss out on this opportunity to gain valuable insights for a successful launch. #MedTech #NHS #productlaunch #webinar

As we embrace a future where healthcare is more connected, the ability to monitor patients remotely and prioritize preventative diagnostics is revolutionizing patient care. Our latest blog post, 'The Evolution of Point-of-Care Testing: What's Next for Healthcare Professionals?' delves into how advancements in point-of-care testing (POCT) are pivotal to this transformation. The spotlight shines on the innovative FIAPro Immunofluorescence Analyzer, a tool at the forefront of these changes, exemplifying the shift towards more immediate, precise, and accessible healthcare diagnostics. This progression towards a more interconnected healthcare ecosystem 🌿 not only enhances the efficiency of patient monitoring but also elevates the importance of preventive diagnostics. By detecting health issues early and accurately, we pave the way for interventions that can significantly alter patient outcomes for the better ✨. Dive into our blog to discover how the evolution of POCT is integral to building a future where healthcare is more proactive, personalized, and preventive 🚀. #PointofCareTesting #FIAPro #FIAProImmunofluorescenceAnalyzer #Vitrosens #VitrosensBiotechnology #InTestWeTrust Visit our website to read our latest blog and follow the latest news in the world of biotechnology. https://lnkd.in/d8aRrWbt

Diagnostics play a crucial role in the healthcare economy by improving patient outcomes, reducing overall healthcare costs, and enhancing operational efficiencies. They also enable the customization of treatments to individual patient needs, improving the effectiveness of therapies and reducing the costs associated with ineffective treatments. Join industry experts Elliot Greenspan, CIO and Co-Founder, Igentify, Lishan Aklog, Chairman and CEO, Lucid Diagnostics Diagnostics, Rollie Carlson, CEO, Immunexpress Inc. and Mike Ward, Head of Thought Leadership for Life Sciences & Healthcare, Clarivate, as they discuss the latest innovations in the field of diagnostics. Watch our on-demand webinar "New frontiers in diagnostics: opportunities and challenges post-pandemic" in our Medtech Resource Center: https://lnkd.in/ea76Ckak #MedTech #Diagnostics #healthcareeconomy

At Diaceutics, we believe that value-based care means delivering the right treatment to the right patient at the right time. To truly realize precision medicine's potential, we need both technological innovation and a shift in healthcare delivery. Recently, we hosted the Precision Medicine Practice Gaps Economic, Policy, and Operational Solutions Global Summit, where global leaders tackled the economic and operational barriers to patient access. With 64% of patients currently missing out on optimal treatments, the Summit highlighted the critical need for robust data integration and new reimbursement frameworks to advance precision medicine.    Read our latest blog which highlights the importance of value-based care, and the steps needed to unlock the power of precision medicine.   Read blog here: https://lnkd.in/dsTEcJ3i   #PrecisionMedicine #ValueBasedCare #HealthcareInnovation

🎉 Partnership Extended! 🎉 We are excited to share that our successful collaboration with Roche continues! Together, we’ve developed advanced digital patient companions like 𝗥𝗲𝘁𝗶𝗻𝗼𝗿𝗮 and 𝗕𝗿𝗶𝘀𝗮, empowering patients living with age-related macular degeneration, diabetic macular edema, retinal vein occlusion and multiple sclerosis. These apps have already made a significant impact, benefiting tens of thousands of patients, with numerous scientific studies confirming their role in improving patients' quality of life and medical care. At the core of these solutions is 𝗧𝗲𝗺𝗲𝗱𝗶𝗰𝗮’𝘀 𝗔𝗽𝗽 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 - a modular system with user-validated features that allows for rapid deployment, scalability, and continuous optimization to enhance patient outcomes and provide real-world insights. With five years of success behind Brisa, we’re excited to expand it and enhance services like OcreKompass for MS patients within Brisa. Our continued partnership with Roche showcases how innovative collaboration, patient engagement, and Real-World Evidence are driving the transformation of healthcare. Together, we continue setting new benchmarks in personalized healthcare. 🌍🔬 👉 Read the full press release here: https://lnkd.in/d5ZFQduC #HealthcareInnovation #DigitalHealth #PatientCare #PersonalizedHealthcare #HealthTech #RealWorldEvidence

Our CEO, John Erbey, sat down with Pulse 2.0 to discuss how Roivios is transforming kidney health management through innovation. Discover how our JuxtaFlow Renal Assist Device (RAD) is redefining conventional kidney care, offering new hope for patients and physicians alike.   With over 25 years in the industry, John shares insights into the serendipitous inception of Roivios, the challenges faced along the way, and the groundbreaking achievements that drive us forward. From FDA Breakthrough Device Designation to life-changing impacts on patients, learn how we're making a difference.   Check out the full article here: https://lnkd.in/gYgBFcKi   #KidneyHealth #Innovation #HealthcareTechnology #Roivios #Pulse20 #MedicalDevice #PatientCare #InnovationInHealth  

🙋🏻♂️ It has been an extraordinary experience attending The Synergist.org - From Testing to Targeted Treatments (FT3) meeting today, on behalf of Blueprint Medicines. Great discussion about the value of precision medicine and how partnerships and collaborations con improve the lives of patients worlwide. My key takeaways: - There is a need to continue raising awareness about precision medicine across healthcare systems - Multi-stakeholders forums are essential to ensure effective access - Collaborative approaches are the cornerstone to improve patient outcomes Congrats Helena Harnik, MBA and your team for organizing this insightful discussion. #patientadvocacy #innovation #precisionmedicine